Alopecia universalis (AU) is a rare autoimmune condition that involves complete loss of hair on your face, scalp, and body.

Roflumilast foam, 0.3% (Zoryve) used once-daily significantly improved itch and other symptoms of plaque psoriasis of the scalp and body, the phase III ARRECTOR trial showed.

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

Johnson & Johnson said on Friday its experimental psoriasis drug met the main goal of a late-stage study, as the once-daily ...

Research led by the SKiN Center for Dermatology observed substantial clearance of scalp and body psoriasis and rapid itch reduction in patients treated with roflumilast foam, 0.3%. Findings indicated ...

Johnson & Johnson (JNJ) posts promising late-stage trial data for plaque psoriasis icotrokinra developed with Protagonist ...

Sounds obvious, but hair growth requires a peaceful environment to be successful. So if your scalp is irritated, inflamed, and flaky, whether due to dandruff, dry scalp, psoriasis, or eczema, you’ll ...

Experts say: A study published in the International Journal of Dermatology found several of the oils in this blend effective ...

Grainne O’Rourke, Founder of Glazed Aesthetics, has a deep-rooted passion for pioneering skincare solutions like Korean Scalp ...

Once-daily roflumilast foam significantly improves scalp and body psoriasis in 8 weeks and was well-tolerated in adolescents ...

Using an existing steroid-free topical foam daily significantly improved the signs and symptoms of psoriasis on the scalp and ...

As part of its ongoing 'Your Health, Our Priority' campaign, Hamad Medical Corporation (HMC) highlighted the exceptional ...